Diminished global arginine bioavailability as a metabolic defect in chronic systolic heart failure

Journal of Cardiac Failure

Volumn 19, Issue 2, 2013, Pages 87-93

  Tang, W H Wilson ^a   Shrestha, Kevin ^a   Wang, Zeneng ^a   Troughton, Richard W ^b   Klein, Allan L ^a   Hazen, Stanley L ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

arginine bioavailability; Heart failure; natriuretic peptide; nitric oxide; prognosis

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ARGININE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CITRULLINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOOP DIURETIC AGENT; NATRIURETIC FACTOR; ORNITHINE; SPIRONOLACTONE;

ADULT; AGED; ARTICLE; ECHOCARDIOGRAPHY; FEMALE; GLOBAL ARGININE BIOAVAILABILITY RATIO; HEART DISEASE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; LEFT VENTRICULAR DIASTOLIC DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; PRIORITY JOURNAL; RIGHT VENTRICULAR SYSTOLIC DYSFUNCTION;

ADULT; AGED; ARGININE; BIOLOGICAL AVAILABILITY; BIOLOGICAL MARKERS; CHRONIC DISEASE; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE, SYSTOLIC; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84873387444     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2013.01.001     Document Type: Article

References (26)

1. X. Loyer, C. Heymes, and J.L. Samuel Constitutive nitric oxide synthases in the heart from hypertrophy to failure Clin Exp Pharmacol Physiol 35 2008 483 488
2. D.M. Kaye, M.M. Parnell, and B.A. Ahlers Reduced myocardial and systemic L-arginine uptake in heart failure Circ Res 91 2002 1198 1203
3. C.R. Morris, G.J. Kato, M. Poljakovic, X. Wang, W.C. Blackwelder, and V. Sachdev Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease JAMA 294 2005 81 90
4. R.W. Troughton, D.L. Prior, J.J. Pereira, M. Martin, A. Fogarty, and A. Morehead Plasma B-type natriuretic peptide levels in systolic heart failure: importance of left ventricular diastolic function and right ventricular systolic function J Am Coll Cardiol 43 2004 416 422
5. T.G. Yandle, E.A. Espiner, M.G. Nicholls, and H. Duff Radioimmunoassay and characterization of atrial natriuretic peptide in human plasma J Clin Endocrinol Metab 63 1986 72 79
6. T.G. Yandle, A.M. Richards, A. Gilbert, S. Fisher, S. Holmes, and E.A. Espiner Assay of brain natriuretic peptide (BNP) in human plasma: evidence for high molecular weight BNP as a major plasma component in heart failure J Clin Endocrinol Metab 76 1993 832 838
7. W.H. Tang, K. Shrestha, F. van Lente, R.W. Troughton, M.G. Martin, and A. Borowski Usefulness of C-reactive protein and left ventricular diastolic performance for prognosis in patients with left ventricular systolic heart failure Am J Cardiol 101 2008 370 373
8. W.H. Tang, W. Tong, R.W. Troughton, M.G. Martin, K. Shrestha, and A. Borowski Prognostic value and echocardiographic determinants of plasma myeloper oxidase levels in chronic heart failure J Am Coll Cardiol 49 2007 2364 2370
9. R.W. Troughton, D.L. Prior, C.M. Frampton, P.J. Nash, J.J. Pereira, and M. Martin Usefulness of tissue doppler and color M-mode indexes of left ventricular diastolic function in predicting outcomes in systolic left ventricular heart failure (from the ADEPT study) Am J Cardiol 96 2005 257 262
10. C.M. Yu, J.E. Sanderson, T.H. Marwick, and J.K. Oh Tissue Doppler imaging a new prognosticator for cardiovascular diseases J Am Coll Cardiol 49 2007 1903 1914
11. L.G. Rudski, W.W. Lai, J. Afilalo, L. Hua, M.D. Handschumacher, and K. Chandrasekaran Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography J Am Soc Echocardiogr 23 2010 685 713
12. W.H. Tang, Z. Wang, L. Cho, D.M. Brennan, and S.L. Hazen Diminished global arginine bioavailability and increased arginine catabolism as metabolic profile of increased cardiovascular risk J Am Coll Cardiol 53 2009 2061 2067
13. H. Sourij, A. Meinitzer, S. Pilz, T.B. Grammer, B.R. Winkelmann, and B.O. Boehm Arginine bioavailability ratios are associated with cardiovascular mortality in patients referred to coronary angiography Atherosclerosis 218 2011 220 225
14. Z. Shao, Z. Wang, K. Shrestha, A. Thakur, A.G. Borowski, and W. Sweet Pulmonary hypertension associated with advanced systolic heart failure: dysregulated arginine metabolism and importance of compensatory dimethylarginine dimethylaminohydrolase-1 J Am Coll Cardiol 59 2012 1150 1158
15. G.A. Haywood, P.S. Tsao, H.E. von der Leyen, M.J. Mann, P.J. Keeling, and P.T. Trindade Expression of inducible nitric oxide synthase in human heart failure Circulation 93 1996 1087 1094
16. R.D. Bernstein, X. Zhang, G. Zhao, P. Forfia, J. Tuzman, and F. Ochoa Mechanisms of nitrate accumulation in plasma during pacing-induced heart failure in conscious dogs Nitric Oxide 1 1997 386 396
17. C.M. Yu, P.C. Fung, G. Chan, K.W. Lai, Q. Wang, and C.P. Lau Plasma nitric oxide level in heart failure secondary to left ventricular diastolic dysfunction Am J Cardiol 88 2001 867 870
18. M. Saitoh, T. Osanai, T. Kamada, T. Matsunaga, H. Ishizaka, and H. Hanada High plasma level of asymmetric dimethylarginine in patients with acutely exacerbated congestive heart failure: role in reduction of plasma nitric oxide level Heart Vessels 18 2003 177 182
19. J. Steppan, S. Ryoo, K.H. Schuleri, C. Gregg, R.K. Hasan, and A.R. White Arginase modulates myocardial contractility by a nitric oxide synthase 1-dependent mechanism Proc Natl Acad Sci U S A 103 2006 4759 4764
20. J.O. O'Neill, P.M. McCarthy, R.C. Brunken, T. Buda, K. Hoercher, and J.B. Young PET abnormalities in patients with nonischemic cardiomyopathy J Card Fail 10 2004 244 249
21. L. Piao, G. Marsboom, and S.L. Archer Mitochondrial metabolic adaptation in right ventricular hypertrophy and failure J Mol Med (Berl) 88 2010 1011 1020
22. E.M. Redout, M.J. Wagner, M.J. Zuidwijk, C. Boer, R.J. Musters, and C. van Hardeveld Right-ventricular failure is associated with increased mitochondrial complex II activity and production of reactive oxygen species Cardiovasc Res 75 2007 770 781
23. H.J. Bogaard, R. Natarajan, S. Mizuno, A. Abbate, P.J. Chang, and V.Q. Chau Adrenergic receptor blockade reverses right heart remodeling and dysfunction in pulmonary hypertensive rats Am J Respir Crit Care Med 182 2010 652 660
24. E. Tatli, T. Kurum, M. Aktoz, and M. Buyuklu Effects of carvedilol on right ventricular ejection fraction and cytokines levels in patients with systolic heart failure Int J Cardiol 125 2008 273 276
25. M. Fukuchi, S.N. Hussain, and A. Giaid Heterogeneous expression and activity of endothelial and inducible nitric oxide synthases in end-stage human heart failure: their relation to lesion site and beta-adrenergic receptor therapy Circulation 98 1998 132 139
26. N.J. Tripolt, A. Meinitzer, M. Eder, T.C. Wascher, T.R. Pieber, and H. Sourij Multifactorial risk factor intervention in patients with type 2 diabetes improves arginine bioavailability ratios Diabet Med 29 2012 e365 e368